High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease

Journal article

Peer reviewed

Faisal M. Sanai, Abdullah S. Alghamdi, Ahmad A. Afghani, Khalid Alswat, Adnan AlZanbagi, Mosfer N. Alghamdi, Abdallah AlMousa, Mohammed Aseeri, Abdullah M. Assiri and Mohamed A. Babatin

Liver international, Vol.38(8), pp.1395-1401

08/2018

PMID: 29288514

Metrics

1 Record Views

Title: High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease
Creators - without role: Faisal M. Sanai - King Abdulaziz Medical City
Abdullah S. Alghamdi - King Fahad Hospital Jeddah
Ahmad A. Afghani - King Fahad Hospital Jeddah
Khalid Alswat - King Saud University
Adnan AlZanbagi - King Abdullah Medical City
Mosfer N. Alghamdi - Armed Forces Hospital
Abdallah AlMousa - King Fahad Specialist Hospital
Mohammed Aseeri - King Abdulaziz Medical City
Abdullah M. Assiri - King Fahd Medical City
Mohamed A. Babatin - King Fahad Hospital Jeddah
Publication Details: Liver international, Vol.38(8), pp.1395-1401
Identifiers: 9920465308331
Academic Unit: King Abdulaziz University; King Saud University; Alfaisal University
Language: English
Resource Type: Journal article